Adaptimmune Therapeutics plc ADR (473A)
Market Open
4 Dec, 17:25
XSTU 
€
0. 05
+0.02
+98%
€
- Market Cap
- P/E Ratio
0% Div Yield
3,000 Volume
-0.44 Eps
€ 0.03
Previous Close Day Range
0.05 0.05
Year Range
0.01 0.66
Want to track 473A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| 473A Adaptimmune Therapeutics plc ADR 5 Dec 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 25 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 24 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 19 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 17 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 14 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 12 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 11 Nov 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 11 Aug 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 14 May 2025 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 7 Aug 2024 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 15 May 2024 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 6 Mar 2024 | | - Cons. EPS | - EPS |
| 473A Adaptimmune Therapeutics plc ADR 8 Nov 2023 | | - Cons. EPS | - EPS |
473A Earnings Reports FAQ
What is the earnings per share (EPS) for 473A?
The current EPS is -0.44.
What is the company's earnings growth rate?
Adaptimmune Therapeutics plc ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2025-12-05, based on the 473A's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Adaptimmune Therapeutics plc ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 473A at this time, as Adaptimmune Therapeutics plc ADR has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
